Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DESI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF710 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAAP100 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SOX12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FKBP15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSUN6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2AFX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF618 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ING5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRLS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101929500 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCCA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on